Navigation Links
New survey shows patient concerns and misinformation impede treatment of menopausal women
Date:7/10/2012

Chevy Chase, MD The Endocrine Society commissioned Lake Research Partners to conduct a national survey of 424 internal medicine, family practice and OB/GYN physicians about their attitudes and experiences related to treating menopausal symptoms. According to the survey, physicians say the primary barrier to women receiving hormone therapy is patients' fears about the risks and their unwillingness to discuss the option. This new survey follows a study conducted in April 2012 among 810 women ages 45 to 60 on the same topic.

Hormone therapy has been under intense scrutiny since 2002, when a large government study called the Women's Health Initiative (WHI) reported that hormone therapyspecifically the combination of estrogen and progestin togetherincreased the risk for blood clots, stroke, breast cancer and heart attacks. The researchers halted the study and concluded that the risks of hormone therapy outweighed the benefits. Although the study was designed to evaluate the role of hormone therapy in the prevention of diseases related to aging, many women and their doctors also abandoned it as therapy for menopausal symptoms.

Over the past 10 years, additional research has found that the level of risk depends on the individual woman, her health history, age, and the number of years since her menopause began. In general, younger women (under 60) who have recently started menopause are at a lower risk than older women when taking low doses of hormone therapy.

"Nearly every physician participating in the survey said menopausal symptoms have a negative impact on quality of life," said William F. Young, Jr., MD, president of The Endocrine Society. "It's important for a woman to know what hormonal and non-hormonal treatment options may be best for them to provide symptom relief, and that's why we developed the Menopause Map."

In May, The Endocrine Society and The Hormone Health Network launched The "Menopause Map", an online int
'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. CWRU nurse researcher surveys infection control practices for home patients
2. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
3. Sexting Common Among Teens: Survey
4. Many Still Tanning, Despite Dangers, Survey Finds
5. Fees Lead Some Kids to Skip After-School Sports: Survey
6. Fewer Young Americans Smoking, Survey Finds
7. Many Primary Care Docs Dont Know Long-Term Effects of Chemo: Survey
8. Half of Young Cigarette Smokers Also Smoke Pot: Survey
9. New gene transfer strategy shows promise for limb girdle and other muscular dystrophies
10. Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia
11. Gel Shows Promise as Future Male Contraceptive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 28, 2015 The buyer power score ... of 5, indicating a medium level of buyer power ... suppliers have equal power during negotiations. One factor helping ... purchasing a health insurance policy from an insurance carrier ... buyers can choose to self-fund their own policy or ...
(Date:4/28/2015)... St. Louis, Missouri (PRWEB) April 28, 2015 ... report that delves into the reality problem Americans ... of the population will need long-term care services as ... will need such care. , In the report, ... from organizations such as the American Health Care Association ...
(Date:4/28/2015)... OsteoRemedies®, LLC, Memphis, TN, offers ... of infected hip and knee arthroplasty. ... pre-formed, pre-loaded spacer with Gentamicin Antibiotics, for consistent ... Combined with a consistent process for polishing ... approved for temporary use for up to 180 ...
(Date:4/28/2015)... 2015 Enrollment in programs designed ... 2.2 million in April, according to the editors ... Medicare-Medicaid Dual Eligibles Database , an online subscription ... the dual-eligible community. This is a 14% increase ... initiatives in January, but only covers about a ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 The PracticeMatch ... from 5:00 to 8:00 pm at the Sheraton Colonial Boston ... 50 hospitals, clinics and groups with career opportunities will be ... Attendees will enjoy free hors d’oeuvres and raffle prize drawings. ... says “Boston is an ideal location to hold a ...
Breaking Medicine News(10 mins):Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 4Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:Enrollment in Duals Programs Increases 14%, New AIS Database Finds 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 3
... REFORM IMPLEMENTATION RECOMMENDS WAYS TO ENSURE ACCESS TO AFFORDABLE ... Full-Year Coverage, Combined Small Business and Individual Health Insurance ... New York, NY, May 19, 2011Modifications to ... and subsidies provided under the Affordable Care Act remain ...
... , WEDNESDAY, May 18 (HealthDay News) -- Long-term ... colon cancers in women with a high risk of breast ... drinking and physical activity affected the risk of several common ... because of family history of breast cancer, age and other ...
... , WEDNESDAY, May 18 (HealthDay News) -- Rep. Gabrielle Giffords, ... assassin, will undergo surgery Wednesday in Houston to replace the ... shooting, according to the Associated Press . This ... days after the three-term Democratic congresswoman from Arizona traveled to ...
... (HealthDay News) -- End-of-life care for older people with advanced ... Canadian province of Ontario, a new study says. U.S. ... much more use of hospital and emergency room services, according ... the Ontario Cancer Registry. The information was collected from people ...
... Rochester Medical Center researchers have pinpointed two genes that ... providing data to support a new investigational treatment that ... Tony Godfrey, Ph.D., a research associate professor of Surgery ... was published by the journal Clinical Cancer Research. ...
... form of childhood cancer acute lymphoblastic leukemia are ... best efforts and the most powerful modern cancer drugs. ... the University of California, San Francisco have uncovered the basis ... use to stay alive. Targeting this protein may be the ...
Cached Medicine News:Health News:New report on health reform implementation: How to ensure access to coverage is maintained 2Health News:New report on health reform implementation: How to ensure access to coverage is maintained 3Health News:Smoking Raises Odds for Cancer in Women Already at High Risk 2Health News:Rep. Giffords to Get Skull Patch in Latest Step in Recovery 2Health News:Rep. Giffords to Get Skull Patch in Latest Step in Recovery 3Health News:End-of-Life Care Differs Between U.S., Canada, Study Finds 2Health News: Researchers home in on genetic signature of esophageal cancer 2Health News: Researchers home in on genetic signature of esophageal cancer 3Health News:UCSF team discovers key to fighting drug-resistant leukemia 2Health News:UCSF team discovers key to fighting drug-resistant leukemia 3
(Date:4/28/2015)...  Boston Scientific Corporation (NYSE: BSX ) ... quarter ended March 31, 2015, compared to the ... to $1.800 billion.  This represents 6 percent operational ... and flat revenue on a reported basis, all ... achieved adjusted earnings per share of $0.21 for ...
(Date:4/28/2015)... PARSIPPANY, N.J. and INDIANAPOLIS , ... who undergo an angioplasty procedure and receive a heart stent ... help prevent a heart attack, a blood clot in their ... survey conducted by Harris Poll found that 52 percent of ... missed taking or changed the way they take their prescribed ...
(Date:4/28/2015)... April 28, 2015  Shares of Celladon Corp. (NASDAQ: ... yesterday following the announcement of poor drug trial results of ... gene therapy agent, MYDICAR.  The selloff may be warranted ... company at bargain basement prices. An analyst ... overview, current pipeline, financial review, analyst summary, valuation, and ...
Breaking Medicine Technology:Boston Scientific Announces Results for First Quarter 2015 2Boston Scientific Announces Results for First Quarter 2015 3Boston Scientific Announces Results for First Quarter 2015 4Boston Scientific Announces Results for First Quarter 2015 5Boston Scientific Announces Results for First Quarter 2015 6Boston Scientific Announces Results for First Quarter 2015 7Boston Scientific Announces Results for First Quarter 2015 8Boston Scientific Announces Results for First Quarter 2015 9Boston Scientific Announces Results for First Quarter 2015 10Boston Scientific Announces Results for First Quarter 2015 11Boston Scientific Announces Results for First Quarter 2015 12Boston Scientific Announces Results for First Quarter 2015 13Boston Scientific Announces Results for First Quarter 2015 14Boston Scientific Announces Results for First Quarter 2015 15Boston Scientific Announces Results for First Quarter 2015 16Boston Scientific Announces Results for First Quarter 2015 17Boston Scientific Announces Results for First Quarter 2015 18Boston Scientific Announces Results for First Quarter 2015 19Boston Scientific Announces Results for First Quarter 2015 20Boston Scientific Announces Results for First Quarter 2015 21Boston Scientific Announces Results for First Quarter 2015 22Boston Scientific Announces Results for First Quarter 2015 23Boston Scientific Announces Results for First Quarter 2015 24Boston Scientific Announces Results for First Quarter 2015 25Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 2Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 3Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 4Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 5Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 6Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 7Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 8Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 9Examining what's Left after MYDICAR Drug Trial Ends In Failure; Celladon Corp. Analyst Report Issued by BrokerBank Securities, Inc. 2
... Knopp Neurosciences Inc. ("Knopp"),announced that the U.S. ... Development has granted orphan drug designation to ... (ALS). (Logo: http://www.newscom.com/cgi-bin/prnh/20070924/KNOPPLOGO ) ... studies to evaluate the safety,tolerability and pharmacokinetics ...
... on stringent endpoint of clinical ... PHILADELPHIA, Oct. 15 An analysis of data to,be ... Scientific Meeting found that Asacol, dosed at 2.4 g/day, ... active,ulcerative colitis (UC). The analysis was based on data ...
Cached Medicine Technology:Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS 2New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 2New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 3New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 4
... Insta Test is an immunochromatography ... It is designed for qualitative ... specimens. The presence of myoglobin ... or higher can be detected ...
This advanced digital monitor detects the appearance of an irregular heartbeat during measurement and gives a warning signal with your reading. An irregular heartbeat may cause or indicate cardiovasc...
... (PSA) is a serine protease that is found ... of the acini and ducts. Normal PSA concentration ... Reports have suggested that elevated level of whole ... tumor markers in diagnosis of prostate cancers. InstaTest ...
... 25-Hydroxyvitamin D Assay is for use only ... Nichols Advantage® 25-Hydroxyvitamin D Assay is intended ... (25-OH-D) and other hydroxylated metabolites of vitamin ... used as an aid in the assessment ...
Medicine Products: